We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
New tool uses artificial intelligence to assess hospital data and help predict patients at risk of becoming long stayers, with resulting negative implications.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
Forms and guidance for professionals working with restricted patients (mentally disordered offenders).
Background information and advice on coronavirus (COVID-19) for health and care professionals.
Interim guidance to support NHS Trusts in managing the de-isolation and discharge of mpox-infected patients.
Constant Attendance Allowance - extra money to help pay for care if you get Industrial Injuries Disablement Benefit or a War Disablement Pension
There have been very rare reports of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) with pseudoephedrine.
Capitation is an example of a potential new payment model to enable integrated care.
Find out about the long-term effects some people can have after having COVID-19.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Actions that trial sponsors should consider to build resilience into clinical trial design
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
Sets out COVID-19 testing for hospice patients and staff.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
A patient alert card is being introduced for men taking finasteride to help raise awareness of the risk of psychiatric side effects and sexual dysfunction, including the potential for sexual dysfunction to persist after treatment has stopped. Healthcare professionals are...
Information for patients, healthcare professionals and developers of new medicines
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.